Enhancement of bioavailability of cinnarizine from its beta-cyclodextrin complex on oral administration with DL-phenylalanine as a competing agent.
D000284:Administration, Oral; D000818:Animals; D001682:Biological Availability; D002626:Chemistry, Pharmaceutical; D002936:Cinnarizine / Q000008:administration & dosage / Q000378:metabolism*; D003505:Cyclodextrins / Q000008:administration & dosage / Q000378:metabolism*; D003912:Dextrins / Q000378:metabolism*; D004285:Dogs; D010649:Phenylalanine / Q000008:administration & dosage*; D010879:Piperazines / Q000378:metabolism*; D013213:Starch / Q000378:metabolism*; D047392:beta-Cyclodextrins
D003505:Cyclodextrins; D003912:Dextrins; D010879:Piperazines; D047392:beta-Cyclodextrins; D002936:Cinnarizine; D010649:Phenylalanine; D013213:Starch; C031215:betadex